RRC ID 38484
著者 Murata M, Nakano K, Tahara K, Tozuka Y, Takeuchi H.
タイトル Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers.
ジャーナル Eur J Pharm Biopharm
Abstract The aim of this study was to investigate the feasibility of surface-modified liposomes for pulmonary delivery of a peptide. Chitosan oligosaccharide (oligoCS) and polyvinyl alcohol with a hydrophobic anchor (PVA-R) were used as surface modifiers. The effect of liposomal surface modification on the behavior of the liposomes on pulmonary administration and potential toxicity were evaluated in vitro and in vivo. In an association study with A549 cells, PVA-R modification reduced interaction with A549 cells, whereas oligoCS modification electrostatically enhanced cellular interaction. The therapeutic efficacy of elcatonin (eCT) after pulmonary administration to rats was significantly enhanced and prolonged for 48 h after separate administration with oligoCS- or PVA-R-modified liposomes. oligoCS-modified liposomes adhered to lung tissues and caused opening of tight junctions, which enhanced eCT absorption. On the other hand, PVA-R-modified liposomes induced long-term retention of eCT in the lung fluid, leading to sustained absorption. Consequently, surface modification of liposomes with oligoCS or PVA-R has potential for effective peptide drug delivery through pulmonary administration.
巻・号 80(2)
ページ 340-6
公開日 2012-2-1
DOI 10.1016/j.ejpb.2011.10.011
PII S0939-6411(11)00306-7
PMID 22036988
MeSH Animals Calcitonin / administration & dosage Calcitonin / analogs & derivatives* Calcitonin / pharmacokinetics Calcitonin / toxicity Cell Line, Tumor Chitosan / chemistry* Delayed-Action Preparations Drug Carriers / chemistry Drug Delivery Systems* Feasibility Studies Humans Liposomes Lung / metabolism Male Oligosaccharides / chemistry Polyvinyl Alcohol / chemistry* Rats Rats, Wistar Time Factors Tissue Distribution Toxicity Tests
IF 4.604
引用数 37
WOS 分野 PHARMACOLOGY & PHARMACY
リソース情報
ヒト・動物細胞 A549(RCB0098)